Skip to content
TrustList
Lexeo Therapeutics logo
Venture capital firm

Lexeo Therapeutics

Gene therapy developer working on heart and central nervous system diseases with a genetic cause

Lexeo Therapeutics cover

TrustList summary

Lexeo Therapeutics is a gene therapy company in New York. It develops treatment candidates for rare inherited conditions and for diseases that affect larger groups of patients. The company grew out of gene therapy research at Weill Cornell Medicine's Department of Genetic Medicine.

Services

  • Cardiac programs: candidates for Friedreich's ataxia and arrhythmogenic cardiomyopathy.
  • Central nervous system programs: candidates aimed at Alzheimer's disease and CLN2 Batten disease.
  • AAV delivery: adeno-associated viruses engineered to carry therapeutic genes to patients.
  • Patient resources: pages on clinical trials, expanded access and patient materials.

Key facts

  • Based in: New York, USA
  • Founded: 2018
  • Approach: engineered adeno-associated virus gene transfer
  • Disease areas: cardiovascular and central nervous system conditions with a genetic definition

Summary written by TrustList from the business's own published information, Oct 2026.

Categories & features

What the business tells TrustList

Founded
2018 (8 years) evidence sent

Ask TrustList to introduce you to Lexeo Therapeutics

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Lexeo Therapeutics

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Lexeo Therapeutics.

Lexeo Therapeutics alternatives

Similar listings buyers compare against this one.

Alternative investment manager covering private equity, real estate, structured finance and special situations, with a China focus

Corporate venture arm of an energy company investing in high-growth energy and mobility technology businesses

Member-managed angel and seed capital fund in Indiana and Arkansas investing in early-stage technology businesses

Egyptian startup investor and accelerator running general and fintech tracks for early-stage founders